Cleared Traditional

SLIMUS (K192970) - FDA 510(k) Clearance

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K192970 · Hironic Co., Ltd. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2020
Decision
405d
Days
Class 2
Risk

K192970 is an FDA 510(k) clearance for the SLIMUS. Classified as Laser For Disruption Of Adipocyte Cells For Aesthetic Use (product code PKT), Class II - Special Controls.

Submitted by Hironic Co., Ltd. (Yongin-Si, KR). The FDA issued a Cleared decision on December 1, 2020 after a review of 405 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.5400 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General & Plastic Surgery submissions.

View all Hironic Co., Ltd. devices

Submission Details

510(k) Number K192970 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 23, 2019
Decision Date December 01, 2020
Days to Decision 405 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
290d slower than avg
Panel avg: 115d · This submission: 405d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code PKT Laser For Disruption Of Adipocyte Cells For Aesthetic Use
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.5400
Definition Laser Intended For The Disruption Of Adipocyte Cells Indicated For Body Contouring Or Reduction In Circumference Of Body Areas.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

E & M
Sanghwa Myung

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - PKT Laser For Disruption Of Adipocyte Cells For Aesthetic Use

All 15
Devices cleared under the same product code (PKT) and FDA review panel - the closest regulatory comparables to K192970.
EON
K211681 · Dominion Aesthetic Technologies, Inc. · Mar 2022
BodySculp
K212331 · Rohrer Aesthetics, LLC · Nov 2021
Powersculp laser lipolysis system
K211402 · Lotuxs Medtech (Suzhou) Co., Ltd. · Jul 2021
Diode Laser Body Sculpture System
K201731 · Shanghai Apolo Medical Technology Co., Ltd. · Sep 2020
Powersculp laser lipolysis system
K191068 · Wuhan Lotuxs Technology Co., Ltd. · Jul 2019
Eon FR
K180511 · Dominion Aesthetic Technologies, Inc. · Jun 2019